Canada markets close in 24 minutes

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.70+0.33 (+3.52%)
At close: 04:00PM EDT
9.63 -0.07 (-0.72%)
After hours: 07:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
45,233
43,876
39,681
10,000
3,413
-
Cost of Revenue
41,305
42,587
48,275
0
-
-
Gross Profit
3,928
1,289
-8,594
10,000
-
-
Operating Expenses
Research Development
262,109
241,226
155,696
135,271
63,319
-
Selling General and Administrative
119,356
110,822
81,599
57,682
25,258
-
Total Operating Expenses
380,463
351,349
237,133
192,775
88,028
-
Operating Income or Loss
-376,535
-350,060
-245,727
-182,775
-84,615
-
Interest Expense
98
97
55
2,952
1,360
-
Total Other Income/Expenses Net
-824
-1,087
52
-825
-1,367
-
Income Before Tax
-358,953
-332,128
-239,476
-186,479
-87,006
-
Income Tax Expense
-4,841
-4,062
0
0
-
-
Income from Continuing Operations
-354,112
-328,066
-239,476
-186,479
-87,006
-
Net Income
-354,112
-328,066
-239,476
-186,479
-87,006
-
Net Income available to common shareholders
-354,112
-328,066
-239,476
-186,479
-87,006
-
Basic EPS
-1.46
-
-1.36
-1.49
-0.77
-0.55
Diluted EPS
-1.46
-
-1.36
-1.49
-0.77
-0.55
Basic Average Shares
198,763
-
175,537
125,348
112,466
112,466
Diluted Average Shares
198,763
-
175,537
125,348
112,466
112,466